Novel concepts for analgesia in severe pain - current strategies and future innovations

European Journal of Pain Supplements

Volumn 3, Issue 1, 2009, Pages 6-10

  Schäfer, Michael ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

17 METHYLNALTREXONE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALVIMOPAN; AMITRIPTYLINE; CLONIDINE; DULOXETINE; GABAPENTIN; GLUTAMIC ACID; HARKOSERIDE; KETAMINE; METHADONE; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; NORADRENALIN; OPIATE; OPIATE RECEPTOR; OXYCODONE; SEROTONIN; SUBSTANCE P; TAPENTADOL; YOHIMBINE;

ANALGESIA; ANALGESIC ACTIVITY; ARTICLE; CHRONIC PAIN; CONSTIPATION; DISEASE MODEL; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENCY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG TOLERABILITY; DRUG UPTAKE; HUMAN; HYPERALGESIA; IN VITRO STUDY; IN VIVO STUDY; MONONEUROPATHY; NAUSEA; NEUROPATHIC PAIN; NEUROTRANSMITTER RELEASE; NONHUMAN; OPIOID INDUCED EMESIS; PAIN; POLYNEUROPATHY; PRIORITY JOURNAL; RECEPTOR AFFINITY; SYNAPSE; TREATMENT OUTCOME;

EID: 70149116082     PISSN: 17543207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1754-3207(09)70003-3     Document Type: Article

References (27)

1. Authier N., Coudore F., Eschalier A., and Fialip J. Pain related behaviour during vincristine-induced neuropathy in rats. NeuroReport 10 (1999) 965-968
2. Ballantyne J.C. Opioids for chronic nonterminal Pain. South Med J 99 11 (2006) 1245-1255
3. Barann M., Urban B., Stamer U., Dorner Z., Bönisch H., and Brüss M. Effects of tramadol and O-demethyl-tramadol on human 5-HT reuptake carriers and human 5-HT3A receptors: a possible mechanism for tramadol-induced early emesis. Eur J Pharmacol 531 1-3 (2006) 54-58
4. Bennett G.I., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
5. Beyreuther B., Callizot N., and Stohr T. Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy. Eur J Pharmacol 539 (2006) 64-70
6. Blyth F.M., March L.M., Brnabic A., et al. Chronic pain in Australia: a prevalence study. Pain 89 (2001) 127-134
7. Breivik H., Collett B., Ventafridda V., Cohen R., and Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 10 (2006) 287-333
8. Briley M. Clinical experience with dual action antidepressants in different chronic pain syndromes. Hum Psychopharmacology 19 (2004) S21-S25
9. Christoph T., Meen M., de Vry J., and Tzschentke T. Efficacy of tapentadol, a novel centrally acting analgesic with dual mode of action, in animal models of chronic neuropathic pain. Eur J Pain 11 Suppl 1 (2007) 61
10. Courteix C., Eschalier A., and Lavarenne J. Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain 53 (1993) 81-88
11. In: Crombie I.K., Croft P.R., Linton S.J., Le Resche L., and Von Korff M. (Eds). Epidemiology of Pain (1999), IASP Press, Seattle
12. Fukuda H., Suenaga K., Tsuchida D., Mantyh C.R., Pappas T.N., Hicks G.A., DeHaven-Hudkins D.L., and Takahashi T. The selective mu opioid antagonist, alvimopan, improves delayed GI transit of postoperative ileus in rats. Brain Res 1102 (2006) 63-70
13. Kim S.H., and Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50 (1992) 355-363
14. Koch S., Hemrick-Luecke S.K., Thompson L.K., Evans D.C., Threlkeld P.G., Nelson D.L., Perry K.W., and Bymaster F.P. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats. Neuropharmacology 45 7 (2003) 935-944
15. Luccarini P., Perrier L., Degoulange C., Gaydier A.-M., and Dallel R. Synergistic antinociceptive effect of amitriptyline and morphine in the rat orofacial formalin test. Anesthesiology 100 3 (2004) 690-696
16. Matthews E.A., and Dickenson A.H. A combination of gabapentin and morphine mediates enhanced inhibitory effects on dorsal horn neuronal responses in a rat model of neuropathy. Anesthesiology 96 3 (2002) 633-640
17. Max M.B., Lynch S.A., Muir J., Shoaf S.E., Smoller B., and Dubner R. Effectsofdesipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326 (1992) 1250-1256
18. Meissner W., Leyendecker P., Müller-Lissner S., Nadstawek J., Hopp M., Ruckes C., Wirz S., Fleischer W., and Reimer K. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation. Eur J Pain 13 1 (2008) 56-64
19. Miyamoto H., Saito Y., Kirihara Y., Hara K., Sakura S., and Kosaka Y. Spinal coadministration of ketamine reduces the development of tolerance to visceral as well as somatic antinociception during spinal morphine infusion. Anesth Analg 90 (2000) 136-141
20. Munro G., Baek C.A., Erichsen H.K., Nielsen A.N., Nielsen E.O., Scheel-Kruger J., Weikop P., and Peters D. The novel compound (+/-)-1-[10-((E)-3-Phenyl-allyl)-3,10-diazabicyclo[4.3.1]dec-3-yl]-propa n-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol. Neuropharmacology 54 2 (2008) 331-343
21. 2A-adrenoceptors in morphine analgesia, tolerance and withdrawal in mice. Eur J Pharmacol 497 (2004) 161-171
22. Pelissier T., Laurido C., Kramer V., Hernández A., and Paeile C. Antinociceptive interactions of ketamine with morphine or methadone in mononeuropathic rats. Eur J Pharmacol 477 (2003) 23-28
23. Smith H. Combination opioid analgesics. Pain Physician 11 (2008) 201-214
24. Tzschentke T.M., Christoph T., Kögel B., Schiene K., Hennies H.-H., Englberger W., Haurand M., Jahnel U., Cremers T., Friderichs E., and De Vry J. (-)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (Tapentadol HCl): A novel μ opioid receptor agonist/norepinephrine reuptake inhibitor with broad spectrum analgesic properties. JPET 323 (2007) 265-276
25. Tzschentke T.M., de Vry J., Terlinden R., Hennies H.-H., Lange C., Strassburger W., Haurand M., Kolb J., Schneider J., Buschmann H., Finkam M., Jahnel U., and Friderichs E. Tapentadol hydrochloride. Drugs Fut 31 12 (2006) 1053-1061
26. Tzschentke TM. Poster 227: Efficacy profile of tapentadol, a novel centrally acting analgesic with a combined mode of action, in animal pain models. 27th American Pain Society Annual Meeting, 2008.
27. Verhaak P.F., Kerssens J.J., Dekker J., Sorbi M.J., and Bensing J.M. Prevalence of chronic benign pain disorder among adults: a review of the literature. Pain 77 (1998) 231-239